Similar Items: Blood protein biomarkers in hepatocellular carcinoma: progress and challenges
- Clinical outcomes with first-line tislelizumab plus lenvatinib in unresectable hepatocellular carcinoma: a retrospective analysis
- Research progress on exercise fatigue from the perspective of fatigue biomarkers
- Bioactivity of Cyperus amuricus extracts against hepatocellular carcinoma and molecular docking analysis targeting the PI3K/AKT/mTOR pathway
- Construction of nomograms for predicting overall survival and progression-free survival in patients with high-grade serous ovarian carcinoma: a retrospective study
- Research progress on glycolytic reprogramming in ophthalmic diseases
- Identification and validation of biomarkers associated with lactic acid metabolism in diabetic nephropathy